全文获取类型
收费全文 | 15435篇 |
免费 | 909篇 |
国内免费 | 1026篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 335篇 |
妇产科学 | 40篇 |
基础医学 | 883篇 |
口腔科学 | 3篇 |
临床医学 | 1865篇 |
内科学 | 5491篇 |
皮肤病学 | 27篇 |
神经病学 | 54篇 |
特种医学 | 543篇 |
外国民族医学 | 2篇 |
外科学 | 2636篇 |
综合类 | 2998篇 |
预防医学 | 440篇 |
眼科学 | 5篇 |
药学 | 1165篇 |
10篇 | |
中国医学 | 522篇 |
肿瘤学 | 347篇 |
出版年
2024年 | 11篇 |
2023年 | 234篇 |
2022年 | 364篇 |
2021年 | 563篇 |
2020年 | 543篇 |
2019年 | 381篇 |
2018年 | 376篇 |
2017年 | 425篇 |
2016年 | 604篇 |
2015年 | 515篇 |
2014年 | 1043篇 |
2013年 | 1071篇 |
2012年 | 939篇 |
2011年 | 1041篇 |
2010年 | 903篇 |
2009年 | 828篇 |
2008年 | 784篇 |
2007年 | 864篇 |
2006年 | 840篇 |
2005年 | 688篇 |
2004年 | 529篇 |
2003年 | 507篇 |
2002年 | 458篇 |
2001年 | 374篇 |
2000年 | 304篇 |
1999年 | 262篇 |
1998年 | 227篇 |
1997年 | 216篇 |
1996年 | 206篇 |
1995年 | 159篇 |
1994年 | 144篇 |
1993年 | 113篇 |
1992年 | 102篇 |
1991年 | 94篇 |
1990年 | 102篇 |
1989年 | 97篇 |
1988年 | 74篇 |
1987年 | 55篇 |
1986年 | 42篇 |
1985年 | 46篇 |
1984年 | 45篇 |
1983年 | 17篇 |
1982年 | 27篇 |
1981年 | 26篇 |
1980年 | 26篇 |
1979年 | 25篇 |
1978年 | 22篇 |
1977年 | 16篇 |
1976年 | 12篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 20 毫秒
1.
《Pancreatology》2022,22(8):1175-1180
BackgroundHepatic steatosis has been described as a common finding in adults following total pancreatectomy with islet autotransplantation (TPIAT) but it is unknown if this occurs in children and adolescents.ObjectivesTo define the frequency of post-TPIAT hepatic steatosis in a sample of children and adolescents and to identify clinical predictors of incident steatosis post-TPIAT.MethodsIn this prospective study, consecutive participants at least 1-month post-TPIAT underwent a liver MRI with proton density fat fraction (PDFF) and blood draw at our pediatric academic medical center between April 2021 and January 2022. Comparison clinical pre-TPIAT liver MRI or ultrasound and insulin use and graft function data were extracted from the medical record. T-tests were used for the comparison of means across continuous variables between participants with and without post-TPIAT steatosis.ResultsA total of 20 participants (mean: 13 ± 4 years; 12 female) were evaluated. Mean liver PDFF at research MRI was 7.4 ± 6.2% (range: 2–25%). Seven participants (35%) had categorical hepatic steatosis (PDFF>5%) post-TPIAT, five of whom had pre-TPIAT steatosis, reflecting a 13% (2/15; 95% CI: 2–40%) incidence of post-TPIAT steatosis. Participant characteristics were not significantly different between subgroups with and without post-TPIAT steatosis. Mean PDFF at research MRI was not different between graft function subgroups (7.5% optimal/good vs. 7.3% marginal/failure; p = .96).ConclusionOur study shows a moderate prevalence but low incidence of hepatic steatosis in a small sample of children and adolescents post-TPIAT. This study raises questions about a causal relationship between TPIAT and hepatic steatosis. 相似文献
2.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
3.
4.
5.
6.
7.
8.
急性胰腺炎是一种起病急、病情危、进展快的临床危重症,其发病原因较为多样,易引发多种并发症,患者病死率较高,随着近些年医疗技术的不断进步,微创治疗已逐渐成为急性胰腺炎重要干预手段之一,使急性胰腺炎的综合治疗水平得以明显提升。本文作者拟结合临床经验,参考相关文献资料,就急性胰腺炎微创治疗的研究进展加以综述,以期为改善急性胰腺炎患者预后提供临床参考。 相似文献
9.
Acute and chronic gastrointestinal problems are common in the setting of excessive alcohol use, and excessive alcohol use is associated with injury to all parts of the gastrointestinal tract. There is mounting evidence of gastrointestinal injury and increased cancer risk even from moderate alcohol consumption. The major causes of alcohol-related morbidity and mortality within the gastrointestinal system are liver disease, pancreatitis and gastrointestinal cancer. Other alcohol-related intestinal dysfunction is common but not life-threatening, leading to diarrhoea, malabsorption and nutritional deficiencies. This review describes non-neoplastic and neoplastic alcohol-related disorders of the gastrointestinal tract, omitting the liver, which has been reviewed elsewhere. 相似文献
10.
Lumir Kunovsky Petr Dite Petr Jabandziev Jiri Dolina Jitka Vaculova Martin Blaho Martina Bojkova Jana Dvorackova Magdalena Uvirova Zdenek Kala Jan Trna 《World journal of gastrointestinal oncology》2021,13(8):835-844
Helicobacter pylori (H. pylori) is an infectious agent influencing as much as 50% of the world’s population. It is the causative agent for several diseases, most especially gastric and duodenal peptic ulcer, gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma of the stomach. A number of other, extragastric manifestations also are associated with H. pylori infection. These include neurological disorders, such as Alzheimer’s disease, demyelinating multiple sclerosis and Parkinson’s disease. There is also evidence for a relationship between H. pylori infection and such dermatological diseases as psoriasis and rosacea as well as a connection with infection and open-angle glaucoma. Generally little is known about the relationship between H. pylori infection and diseases of the pancreas. Most evidence about H. pylori and its potential role in the development of pancreatic diseases concerns pancreatic adenocarcinoma and autoimmune forms of chronic pancreatitis. There is data (albeit not fully consistent) indicating modestly increased pancreatic cancer risk in H. pylori-positive patients. The pathogenetic mechanism of this increase is not yet fully elucidated, but several theories have been proposed. Reduction of antral D-cells in H. pylori-positive patients causes a suppression of somatostatin secretion that, in turn, stimulates increased secretin secretion. That stimulates pancreatic growth and thus increases the risk of carcinogenesis. Alternatively, H. pylori, as a part of microbiome dysbiosis and the so-called oncobiome, is proven to be associated with pancreatic adenocarcinoma development via the promotion of cellular proliferation. The role of H. pylori in the inflammation characteristic of autoimmune pancreatitis seems to be explained by a mechanism of molecular mimicry among several proteins (mostly enzymes) of H. pylori and pancreatic tissue. Patients with autoimmune pancreatitis often show positivity for antibodies against H. pylori proteins. H. pylori, as a part of microbiome dysbiosis, also is viewed as a potential trigger of autoimmune inflammation of the pancreas. It is precisely these relationships (and associated equivocal conclusions) that constitute a center of attention among pancreatologists, immunologists and pathologists. In order to obtain clear and valid results, more studies on sufficiently large cohorts of patients are needed. The topic is itself sufficiently significant to draw the interest of clinicians and inspire further systematic research. Next-generation sequencing could play an important role in investigating the microbiome as a potential diagnostic and prognostic biomarker for pancreatic cancer. 相似文献